Literature DB >> 7078867

Pelvic infection after elective abortion associated with Chlamydia trachomatis.

B R Møller, S Ahrons, J Laurin, P A Mårdh.   

Abstract

Two groups in Denmark and Sweden, totalling 943 healthy women in the first trimester of pregnancy who were undergoing elective abortion, were examined in a prospective study. Group 1 consisted of 432 women from Denmark, all examined prior to and 2 weeks after the operation. At the first examination, samples were taken from the cervix for the isolation of chlamydiae and gonococci. Chlamydia trachomatis was isolated from 23 (5.3%) of the women. Postoperatively, 15 patients developed acute pelvic inflammatory disease (PID). Five of these patients harbored C trachomatis before the operation, and all 5 developed a significant change in the titer of immunoglobulin G microimmunofluorescence antibodies to the organism. In group 2, 25 (4.9%) of the 511 women from Sweden harbored C trachomatis before the intervention. Patients with chlamydiae were treated, before or in conjunction with the operation, with antibiotics active against chlamydiae. None of the women with cultures positive for chlamydiae showed signs of PID postoperatively. The difference in the postoperative frequency of PID in chlamydia-positive patients between groups 1 and 2 was significant (2P = .0393, Fisher exact test). Gonorrhea was diagnosed in 1% of the women in both groups. Only 1 of these patients developed PID postoperatively, but no pili antibodies to Neisseria gonorrhoeae were found during the course of the disease. It is concluded that women applying for abortion should be examined and treated not only for gonorrhea but also for infection with C trachomatis either before or, at the latest, in conjunction with the abortion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078867

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Endocervical Chlamydia trachomatis infection in Canadian adolescents.

Authors:  E G Hughes; J Mowatt; J E Spence
Journal:  CMAJ       Date:  1989-02-01       Impact factor: 8.262

2.  Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection.

Authors:  H Mallinson; J Hopwood; S Skidmore; K Fenton; C Phillips; I Jones
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

3.  Chlamydial infection among females attending an abortion clinic: prevalence and risk factors.

Authors:  P Levallois; J E Rioux; L Côté
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

4.  Sentinel surveillance of Chlamydia trachomatis infection in women terminating pregnancy.

Authors:  F E Skjeldestad; S A Nordbø; A Hadgu
Journal:  Genitourin Med       Date:  1997-02

5.  Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy.

Authors:  S M Garland; S Tabrizi; J Hallo; S Chen
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

6.  Pivampicillin in treating genital infection with Chlamydia trachomatis.

Authors:  B R Møller; M Cramers; E From
Journal:  Genitourin Med       Date:  1985-08

7.  Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study.

Authors:  E Qvigstad; K Skaug; F Jerve; P Fylling; J C Ulstrup
Journal:  Br J Vener Dis       Date:  1983-06

8.  Induced abortion: microbiological screening and medical complications.

Authors:  B Stray-Pedersen; J Biørnstad; M Dahl; T Bergan; G Aanestad; L Kristiansen; K Hansen
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

9.  Evaluation of single whole inclusion serum test for IgG antibody to Chlamydia trachomatis in asymptomatic women.

Authors:  M P Meyer; A J Amortegui
Journal:  Genitourin Med       Date:  1987-02

10.  Simplified culture procedure for large-scale screening for Chlamydia trachomatis infections.

Authors:  M I Lees; D M Newnan; S M Garland
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.